Cellular Biomedicine Group, Inc. Contracts & Agreements

Sponsored Collaborative Research Agreement with Duke University, executed on September 21, 2020 (Filed With SEC on November 9, 2020)

BRIDGELOAN AGREEMENT (Filed With SEC on October 26, 2020)

BRIDGE LOAN AGREEMENT (Filed With SEC on October 26, 2020)

Nanjing Bank approval of a credit line of up to RMB 30 million to CBMG Wuxi (Filed With SEC on August 12, 2020)

China Merchants Bank approval of a credit line of up to RMB 30 million to SBM Shanghai (Filed With SEC on August 12, 2020)

U.S. National Heart, Lung, and Blood Institute nonexclusive patent AAV5 License Agreement (certain portions of this exhibit have been omitted because they are both (i) not... (Filed With SEC on August 12, 2020)

Agreement and Plan of Merger, dated as of August 11, 2020, by and among Cellular Biomedicine Group, Inc., CBMG Holdings and CBMG Merger Sub Inc (Filed With SEC on August 12, 2020)

Bridge Loan Agreement, dated as of August 11, 2020, by and between Cellular Biomedicine Group, Inc. and Yunfeng Capital Limited (Filed With SEC on August 12, 2020)

Amendment Letter, dated as of August 11, 2020, by and between Cellular Biomedicine Group, Inc. and Winsor Capital Limited in relation to the Bridge Loan Agreement, dated as of... (Filed With SEC on August 12, 2020)

Nanjing Bank approval of a credit line of up to RMB 30 million to CBMG Wuxi (Filed With SEC on May 6, 2020)

Description of Securities (Filed With SEC on February 28, 2020)

Lease Agreement, dated as of October 1, 2019, by and between the Company and IPX Medical Center Drive Investors, LLC (Filed With SEC on February 28, 2020)

BRIDGE LOAN AGREEMENT (Filed With SEC on January 29, 2020)

Form of Lease Agreement, dated October 1, 2019, by and between the Company and IPX Medical Center Drive Investors, LLC (Filed With SEC on November 6, 2019)

Facility Improvement and Process Validation Agreement (Filed With SEC on August 29, 2019)

Underwriting Agreement, dated March 21, 2019, by and among Cellular Biomedicine Group, Inc., Cantor Fitzgerald& Co. and Robert W. Baird & Co. Incorporated, as representatives of... (Filed With SEC on March 22, 2019)

Lease Agreement, dated December 1, 2018, by and between CBMG Shanghai and Shanghai Guilin Industrial Co., Ltd (Filed With SEC on February 19, 2019)

License Agreement, dated as of February 14, 2019, by and between the Company and Augusta University Research Institute, Inc (Filed With SEC on February 19, 2019)

Credit Agreement, dated as of January 19, 2019, by and between Shanghai Cellular Biopharmaceutical Group Ltd. and China Merchants Bank Co., Ltd., Shanghai Branch (Filed With SEC on January 25, 2019)

Pledge Agreement, dated as of January 9, 2019, by and between Cellular Biomedicine Group Ltd. (HK) and China Merchants Bank Co., Ltd., Shanghai Branch (Filed With SEC on January 25, 2019)

Toll Manufacturing and Supply Agreement, dated December 21, 2018, by and among the Company, Novartis Pharma AG and other parties thereto (Filed With SEC on December 28, 2018)

License Agreement, dated October 2, 2018, by and among the Company and the U.S. Department of Health and Human Services, as represented by the National Cancer Institute, an... (Filed With SEC on October 9, 2018)

Registration Rights Agreement, dated September 26, 2018, by and between the Company and Novartis Pharma AG (Filed With SEC on September 27, 2018)

License and Collaboration Agreement, dated September 25, 2018, by and among the Company, Novartis Pharma AG and other parties thereto (Filed With SEC on September 27, 2018)

Securities Purchase Agreement, dated September 25, 2018, by and among the Company, Novartis Pharma AG and Shanghai Cellular Biopharmaceutical Group Ltd (Filed With SEC on September 27, 2018)

AMENDMENT NO. 1 TO REGISTRATION PURCHASE AGREEMENT (Filed With SEC on February 7, 2018)

AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 7, 2018)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 31, 2018)

SECURITIES PURCHASE AGREEMENT BY AND AMONG CELLULAR BIOMEDICINE GROUP, INC., WEALTH MAP HOLDINGS LIMITED, EARLS MILL LIMITED, AND BOSUN S. HAU JANUARY 30, 2018 TABLEOF CONTENTS (Filed With SEC on January 31, 2018)

SHARE PURCHASE AGREEMENT (Filed With SEC on December 28, 2017)

SHARE PURCHASE AGREEMENT (Filed With SEC on December 21, 2017)

Lease Contract (Filed With SEC on March 13, 2017)

EMPLOYMENT AGREEMENT (Amendedand Restated as of March 3, 2017) (Filed With SEC on March 13, 2017)

Lease Contract (5F) (Filed With SEC on March 13, 2017)

Lease Contract (6F) (Filed With SEC on March 13, 2017)

CONSULTING AGREEMENT (Filed With SEC on March 14, 2016)

Technology Transfer Contract (Filed With SEC on March 14, 2016)

Patent Transfer Agreement among China Pharmaceutical University (as the Transferor) and Cellular Biomedicine Group (Shanghai) Ltd. (As the Transferee) November 16, 2015 (Filed With SEC on March 14, 2016)

Clinical Trial Agreement (Filed With SEC on March 14, 2016)

SHARES PURCHASE AGREEMENT (Filed With SEC on February 10, 2016)

Asset Purchase Agreement, dated June 8, 2015 (Filed With SEC on July 2, 2015)

Assignment and Assumption Agreement, dated June 26, 2015 (Filed With SEC on July 2, 2015)

Amended and Restated Standard Exclusive License Agreement with Sublicensing Terms, dated June 3, 2015 (Filed With SEC on July 2, 2015)

ASSET PURCHASE AGREEMENT by and among BLACKBIRD BIOFINANCE, LLC, as Seller, DR. SCOTT ANTONIA and SAM SHRIVASTAVA as Principals, CELLULAR BIOMEDICINE GROUP, INC. as Parent,... (Filed With SEC on June 12, 2015)

CELLULAR BIOMEDICINE GROUP, INC. SUBSCRIPTION AGREEMENT (Filed With SEC on April 15, 2015)

Framework Agreement, dated August 2, 2014 (with unofficial summary translation) (Filed With SEC on October 2, 2014)

Technology Transfer Agreement, dated September 1, 2014 (Filed With SEC on October 2, 2014)

U.S. Patent Purchase Agreement, dated September 26, 2014 (Filed With SEC on October 2, 2014)

Form of Lockup Agreement (Filed With SEC on October 2, 2014)

Severance Agreement and Release with Keith Wong, dated July 31, 2014 (Filed With SEC on August 8, 2014)

Option Deed (Filed With SEC on July 8, 2014)

Form of Subscription Agreement (Filed With SEC on June 23, 2014)

CELLULAR BIOMEDICINE GROUP, INC. [Letterhead] [Date] (Filed With SEC on April 15, 2014)

CELLULAR BIOMEDICINE GROUP, INC. SUBSCRIPTION AGREEMENT (Filed With SEC on December 16, 2013)

Amendment No. 2 to Employment Agreement with Wei (William) Cao (Filed With SEC on October 2, 2013)

Amendment No. 2 to Employment Agreement with Wen Tao (Steve) Liu (Filed With SEC on October 2, 2013)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on September 5, 2013)

Entrustment Contract on Listing on a U.S. Stock Market (Filed With SEC on June 18, 2013)

SECURITIES PURCHASE AGREEMENT Dated as of December 17, 2012 by and between Eastbridge Investment Group Corp. and Zhang, Hui and MA Platform, Inc. (Filed With SEC on June 18, 2013)

Form of Notice Stock Option Award and Stock Option Award Agreement used under Amended and Restated 2011 Incentive Stock Option Plan (Filed With SEC on May 20, 2013)

EASTBRIDGE INVESTMENT GROUP CORPORATION AMENDED AND RESTATED 2011 INCENTIVE STOCK OPTION PLAN (Filed With SEC on April 4, 2013)

AMENDMENT NO. 3 TO AGREEMENT AND PLAN OF MERGER (Filed With SEC on February 12, 2013)

CONTRIBUTION AGREEMENT (Filed With SEC on February 12, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on February 12, 2013)

Cellular Biomedicine Group [_____________] (Filed With SEC on February 12, 2013)

INDEMNIFICATION AGREEMENT (Filed With SEC on February 12, 2013)

FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on February 12, 2013)

DEFERRED COMPENSATION AGREEMENT (Filed With SEC on February 12, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on February 12, 2013)

AMENDMENT NO.2 TO AGREEMENT AND PLAN OF MERGER (Filed With SEC on February 4, 2013)

Amendment No. 1 to the Agreement and Plan of Merger (Filed With SEC on January 22, 2013)

Securities Purchase Agreement by and among the Company, Hui Zhang and MA Platform, Inc., dated December 17, 2012 (Filed With SEC on January 14, 2013)

Agreement and Plan of Merger, dated November 13, 2012, by and among EastBridge Investment Group Corporation, CBMG Acquisition Limited and Cellular Biomedicine Group Ltd (Filed With SEC on November 20, 2012)

Stock Purchase Agreement between EastBridge Investment Group Corporation, and An Lingyan, dated December 14, 2011 (Filed With SEC on January 3, 2012)

Translated Entrustment Contract on Listing on the U.S. Stock Markets among EastBridge Investment Group Corporation, Hangzhou HaoHai Culture Media Co., Ltd. and China Golden Eagle... (Filed With SEC on November 17, 2011)

Entrustment Contract on Listing on the U.S. Stock Markets (Filed With SEC on June 7, 2011)

CONSULTINGAGREEMENT (Filed With SEC on May 23, 2011)

Entrustment Contract on Listing on the U.S. Stock Markets (Filed With SEC on May 16, 2011)

Bridge Capital Raise Agreement between EastBridge Investment Group Corporation and FIZZA, LLC, dated December 1, 2010 (confidential treatment requested for redacted portions) (Filed With SEC on December 7, 2010)

EastBridge Investment Group Corp.CONFIDENTIAL (Filed With SEC on November 12, 2010)

1 2 3 4 5 (Filed With SEC on April 15, 2010)

US Listing Agreement (Filed With SEC on April 15, 2010)

Business Contract/Plan.Please keep it confidential.Author: EastBridge Investment Group Corp Only limited for the internal use of authorized parties: Author (Should the authorized... (Filed With SEC on April 15, 2010)

ListingAgreement (Filed With SEC on April 15, 2010)

Stock Purchase Agreement with Aoxing Corporation (Filed With SEC on October 22, 2008)

Stock Purchase Agreement with Ji-Bo Pipes & Valves Company (Filed With SEC on October 22, 2008)

Category

Industry

Companies

Contracts

Cellular Biomedicine Group, Inc. Contracts & Agreements